Cargando…
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asth...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321539/ https://www.ncbi.nlm.nih.gov/pubmed/35887681 http://dx.doi.org/10.3390/jpm12071184 |
_version_ | 1784756072753397760 |
---|---|
author | Nicola, Stefania Borrelli, Richard Ridolfi, Irene Bernardi, Virginia Borrelli, Paolo Guida, Giuseppe Antonelli, Andrea Albera, Carlo Marengo, Stefania Briozzo, Antonio Norbiato, Claudio Frazzetto, Agata Valentina Saad, Marina Lo Sardo, Luca Bacco, Beatrice Gallo Cassarino, Silvia Della Mura, Stefano Bagnasco, Diego Bucca, Caterina Rolla, Giovanni Solidoro, Paolo Brussino, Luisa |
author_facet | Nicola, Stefania Borrelli, Richard Ridolfi, Irene Bernardi, Virginia Borrelli, Paolo Guida, Giuseppe Antonelli, Andrea Albera, Carlo Marengo, Stefania Briozzo, Antonio Norbiato, Claudio Frazzetto, Agata Valentina Saad, Marina Lo Sardo, Luca Bacco, Beatrice Gallo Cassarino, Silvia Della Mura, Stefano Bagnasco, Diego Bucca, Caterina Rolla, Giovanni Solidoro, Paolo Brussino, Luisa |
author_sort | Nicola, Stefania |
collection | PubMed |
description | Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities. |
format | Online Article Text |
id | pubmed-9321539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93215392022-07-27 COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy Nicola, Stefania Borrelli, Richard Ridolfi, Irene Bernardi, Virginia Borrelli, Paolo Guida, Giuseppe Antonelli, Andrea Albera, Carlo Marengo, Stefania Briozzo, Antonio Norbiato, Claudio Frazzetto, Agata Valentina Saad, Marina Lo Sardo, Luca Bacco, Beatrice Gallo Cassarino, Silvia Della Mura, Stefano Bagnasco, Diego Bucca, Caterina Rolla, Giovanni Solidoro, Paolo Brussino, Luisa J Pers Med Article Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities. MDPI 2022-07-20 /pmc/articles/PMC9321539/ /pubmed/35887681 http://dx.doi.org/10.3390/jpm12071184 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nicola, Stefania Borrelli, Richard Ridolfi, Irene Bernardi, Virginia Borrelli, Paolo Guida, Giuseppe Antonelli, Andrea Albera, Carlo Marengo, Stefania Briozzo, Antonio Norbiato, Claudio Frazzetto, Agata Valentina Saad, Marina Lo Sardo, Luca Bacco, Beatrice Gallo Cassarino, Silvia Della Mura, Stefano Bagnasco, Diego Bucca, Caterina Rolla, Giovanni Solidoro, Paolo Brussino, Luisa COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title | COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title_full | COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title_fullStr | COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title_full_unstemmed | COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title_short | COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy |
title_sort | copd, but not asthma, is associated with worse outcomes in covid-19: real-life data from four main centers in northwest italy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321539/ https://www.ncbi.nlm.nih.gov/pubmed/35887681 http://dx.doi.org/10.3390/jpm12071184 |
work_keys_str_mv | AT nicolastefania copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT borrellirichard copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT ridolfiirene copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT bernardivirginia copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT borrellipaolo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT guidagiuseppe copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT antonelliandrea copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT alberacarlo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT marengostefania copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT briozzoantonio copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT norbiatoclaudio copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT frazzettoagatavalentina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT saadmarina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT losardoluca copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT baccobeatrice copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT gallocassarinosilvia copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT dellamurastefano copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT bagnascodiego copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT buccacaterina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT rollagiovanni copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT solidoropaolo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly AT brussinoluisa copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly |